Indiana University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Indiana University sits in the top decile of US sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count).
Indiana University: 890 sponsored US clinical trials, 156 recruiting.
Indiana University sponsors 890 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 561 completed. 104 of these trials are in Phase 3-4 (later-stage) and 126 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Alzheimer Disease, with 11 trials.
Top-decile sponsor footprint
Indiana University ranks in the top decile of sponsors by registered trial count (#38 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
561 of 688 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
890 total, page 11 of 18
Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions
NCT03213951
A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver
NCT02966223
Monotherapy Anticoagulation To Expedite Home Treatment of Venous Thromboembolism
NCT03404635
Effects of Soccer Heading on Ocular-motor Function and Blood Biomarker
NCT03488381
Patient-Centered Decision Support to Improve Diabetes Management in Pre-Teens and Adolescents With Type 1 Diabetes
NCT03084900
Comparing Interventions to Increase Colorectal Cancer Screening
NCT03200366
Acute Kidney Injury in Patients Undergoing Contrast Exposure: VQ vs. CT
NCT03116139
B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial
NCT03136198
Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis
NCT03098082
Task-specificity for Locomotor Recovery Following SCI
NCT03144388
Improving Functional Ability in Chronic TBI With Intensive Rehabilitation Robotic Gait Training
NCT03438409
Assessment of a New "Boosting" Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers
NCT03202511
Examining the Effects of Processed Music on Chronic Pain
NCT03083977
Amnion-Chorion Allograft Barrier Used for Root Surface and Guided Tissue Regeneration
NCT03095976
A Pilot Study to Assess Theragnostically Planned Liver Radiation to Optimize Radiation Therapy
NCT03338062
Health Information Technology to Improve Bedtime Media Use in Children
NCT03177421
Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children
NCT02885324
iMETX (Individualized Metabolic RX): a Pilot Study
NCT03158519
Mindfulness to Enhance Quality of Life and Support Advance Care Planning
NCT03257007
G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis
NCT03980145
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440
Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study
NCT03132337
Reactions to E-cigs and Alcohol
NCT03449017
Late Function After Surgery for Transposition of the Great Arteries
NCT03078413
Mobile Critical Care Recovery Program for Acute Respiratory Failure Survivors
NCT03053245
Translating 3-Step Workout for Life in a Local Senior Living Community
NCT03095534
Mobile Enhancement of Motivation in Schizophrenia
NCT03059771
Cognitive Intervention to Improve Memory in Heart Failure Patients
NCT03035565
Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial
NCT03009110
Comparison of Three Different Pain Blocks for Subjects Undergoing VATS (Video Assisted Thoracoscopic Surgery) Procedure.
NCT03151434
A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
NCT02685098
Addressing Place and People Micro Environments in Weight Loss Disparities
NCT03083964
Assessing Outcomes in ED Patients With RV Failure
NCT03073629
Evidence-based Diagnosis and Management of Pediatric Obstructive Sleep Apnea in Primary Care
NCT02781376
Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses
NCT03040323
Decreasing Delirium Through Music
NCT03095443
Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers
NCT02341274
Scheduled Awakenings for the Treatment of Nocturnal Enuresis
NCT03047720
Methadone-Induced QT Interval Prolongation in a Narcotic Treatment Center
NCT02898337
IU Health Krannert Personalized Medicine Study
NCT02955121
Glycosylation of Exosomes in Prostate and Urothelial Carcinoma
NCT04960956
Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents
NCT03085927
RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding
NCT02829957
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
NCT02981888
Pharmacokinetics (PK) and Modeling of Betamethasone Therapy in Threatened Preterm Birth
NCT02793700
Chlorthalidone in Chronic Kidney Disease
NCT02841280
Leg Thermotherapy for Intermittent Claudication
NCT02770547
Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region
NCT02780648
Influence of Testosterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
NCT02513940
Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
NCT02712788
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 56 |
| Phase 2 | 70 |
| Phase 3 | 28 |
| Phase 4 | 76 |
Therapeutic Areas
What is open in the Indiana University pipeline
156 recruiting of 890 indexed (18% open); 561 completed (63%).
Phase mix: 104 late (III/IV) vs 126 early (I/II) (balanced across stages).
Top condition: Alzheimer Disease (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Indiana University: open-pipeline peers nationwide
Peers matched on 890 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Indiana University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 890 trials (± recruiting share)
- University of California, Los Angeles · 897 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Edwards Lifesciences · 18% recruiting · 57 trials
- University of South Florida · 17% recruiting · 252 trials
- VA Office of Research and Development · 17% recruiting · 1,668 trials
- ConvaTec · 18% recruiting · 17 trials
Related
What to do with this Indiana University page
890 registered trials is a research-attention snapshot, not an endorsement of Indiana University or any single study.
- 156 of Indiana University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Alzheimer Disease is the condition Indiana University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Alzheimer Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Indiana University pipeline card: 890 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.